Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Diseas…

Eisai Inc. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings ...

Amyloidosis Global Clinical Trials Market Review 2025: Competitive Strategies in Analyzing Trial Success Rates, Enrollment Trends, and Identifying Cost-effective Locations

The report on "Amyloidosis - Global Clinical Trials Review, 2025" highlights key opportunities by providing insights on trial locations, status, and sponsor types. It aids in strategic investment ...

Sleep Apnea Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

The report identifies opportunities in global sleep apnea clinical trials by analyzing trial data across key regions, highlighting top companies, and reviewing in-progress trials. It aids strategic ...

Inflammatory Bowel Disease Global Clinical Trials Market Review 2025: Insights on Trial Phases, Statuses, and Regional Trends

The report reveals opportunities in the Inflammatory Bowel Disease clinical trials landscape, highlighting strategic locations for trials and identifying top companies involved. It aids in formulating ...

NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic …

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...
University of California, San Francisco

UCSF Cardiologists Share Research, Receive Recognition at Heart Meeting

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Familial Chylomicronemia Syndrome Pipeline Analysis Report 2025: Mechanisms of Action, Competitive Players, Clinical Milestones, and Evolving Therapy Classes

The leading Familial Chylomicronemia Syndrome Companies such as Ionis Pharmaceuticals, Pfizer, Arrowhead Pharmaceuticals, ...
TipRanks on MSN

Sino Biopharmaceutical’s LM-350 Receives Clinical Trial Approval in China

Sino Biopharmaceutical ( ($HK:1177) ) has shared an update. Sino Biopharmaceutical Limited announced that its innovative drug, LM-350 ‘CDH17 ADC’, ...

Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology Transcript

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

Electronic Data Capture Software Market is expected to generate a revenue of USD 4.06 Billion by 2031, Globally, at 14.5% CAGR: Verified Market Research®

The Global Electronic Data Capture Software Market Size projected to grow at a CAGR of 14.5% from 2024 to 2031, according to ...
Heart

Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
MarketWatch

DNA Cancer Vaccine Clinical Trials Report 2026 - Development Technology Platforms & Market Opportunity Outlook to 2030 - ResearchAndMarkets.com

The "DNA Cancer Vaccine Clinical Trials, Development Technology Platforms & Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering. The global impact of cancer ...